An open, multicenter, exploratory study of apatinib mesylate maintenance therapy for recurrent/metastatic head and neck squamous cell carcinoma (ChiCTR1800019375).
- Resource Type
- Article
- Source
- Head & Neck; Apr2024, Vol. 46 Issue 4, p915-925, 11p
- Subject
APATINIB SQUAMOUS cell carcinoma DRUG side effects HEAD & neck cancer HAND-foot syndrome PROGRESSION-free survival - Language
- ISSN
- 10433074